Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

1,187

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Coronary Artery Disease
Interventions
DRUG

Clopidogrel

DAPT using aspirin 81 mg/day (minimal dose) and clopidogrel 75 mg/day should be conducted for 3 months (+ 30 days) after stenting.

Trial Locations (112)

Unknown

Asahi General Hospital, Asahi

Kimitsu Chuo Hospital, Kisarazu

Fukui Cardiovascular Center, Fukui-shi

Fukuoka City Hospital, Fukuoka

Fukuoka City Medical Association Hospital, Fukuoka

Fukuoka Red Cross Hospital, Fukuoka

University of Occupational and Environmental Health, Kita-Kyushu City

National Hospital Organization Fukuoka-Higashi Medical Center, Koga

Gifu Heart Center, Gifu

Fukuyama City Hospital, Fukuyama

Hiroshima Railway Hospital, Hiroshima

Tsuchiya General Hospital, Hiroshima

Engaru-Kosei General Hospital, Monbetsu-gun

Hyogo Prefectural Amagasaki Hospital, Amagasaki

Kansai Rosai Hospital, Cardiovascular Center, Amagasaki

Kobe City Medical Center General Hospital, Kobe

Shakaihoken Kobe Central Hospital, Kobe

Miki City Hospital, Miki

Hyogo College of Medicine, Nishinomiya

Meiwa General Hospital, Nishinomiya

Hyogo Prefectural Awaji Hospital, Sumoto

Kanazawa University Hospital, Kanazawa

Kaisei General Hospital, Sakaidechō

Kagoshima University Hospital, Kagoshima

Tenyoukai Central Hospital, Kagoshima

Ebina General Hospital, Ebina

Fujisawa City Hospital, Fujisawa

Kawasaki Municipal Tama Hospital, Kawasaki

St. Marianna University of Medicine, Toyoko Hospital, Kawasaki

St. Marianna University School of Medicine, Kawasaki

Synthesis Shinkawahashi Hospital, Kawasaki

Odawara Cardiovascular Hospital, Odawara

Kitazato University School of Medicine, Sagamihara

Sagamihara Kyodo Hospital, Sagamihara

Kanagawa Cardiovascular and Reppiratory Center, Yokohama

Saiseikai Yokohama Tobu Hospital, Yokohama

Showa University Fujigaoka Hospital, Yokohama

St. Marianna University of Medicine, Yokohama City West Hospital, Yokohama

Yokohama City University Hospital, Yokohama

Yokohama City UNiversity Medical Center, Yokohama

Kumamoto Chuo Hospital, Kumamoto

Kumamoto Red Cross Hospital, Kumamoto

National Hospital Organization Kumamoto Medical Center, Kumamoto

Saiseikai Kumamoto Hospital, Kumamoto

Sugimura Hospital, Kumamoto

Ijinkai Takeda General Hospital, Kyoto

Koseikai Takeda Hospital, Kyoto

Kyoto Second Red Cross Hospital, Kyoto

Gakken The Holy City Medical Association Hospital, Sagara-gun

Uji Tokushukai Hospital, Uji

Matsuzaka Central General Hospital, Matsuzaka City

Suzuka Central General Hospital, Suzuka

Mie Heart Center, Taki-gun

Mie University Hospital, Tsu

Nagasaki University Graduate School of Biomedical Science, Nagasaki

Kawasaki Medical School, Kurashiki

National Hospital Organization Okayama Medical Center, Okayama

The Sakakibara Heart Institute of Okayama, Okayama

Ohama Daiichi Hospital, Naha

Nakagami Hospital, Okinawa

Okinawa Nanbu Tokushukai Hospital, Shimajiri-gun

Urasoe General Hospital, Urasoe

Kawachi General Hospital, Higashiosaka

Kansai Medical University Hirakata Hospital, Hirakata

Kansai Medical University Takii Hospital, Moriguchi

Komatsu General Hospital, Neyagawa

Higashi-sumiyoshi Morimoto Hospital, Osaka

Nissay Hospital, Osaka

Osaka City General Hospital, Osaka

Osaka City University, Graduate School of Medicine, Osaka

Osaka Ekisaikai Hospital, Osaka

Osaka General Hospital of West Japan Railway Campany, Osaka

Osaka General Medical Center, Osaka

Osaka Gyoumeikan Hospital, Osaka

Osaka Police Hospital, Osaka

Sakurabashi Watanabe Hospital, Osaka

Bell Land General Hospital, Sakai

Mimihara General Hospital, Sakai

National Cerebral and Cardiovascular Center, Suita

Osaka University Graduate School of Medicine, Suita

Saiseikai Senri Hospital, Suita

Hokusetsu General Hospital, Takatsuki

Midorigaoka Hospital, Takatsuki

Department of Cardiovascular Medicine, Saga University, Saga

Mashiko Hospital, Kawaguchi

Saitama Medical Center, Jichi Medical University, Saitama

Kusatsu Heart Center, Kusatsu

Shiga Medical Center for Adults, Moriyama

Omihachiman Community Medical Center, Ōmihachiman

Biwako Ohashi Hospital, Ōtsu

Hamamatsu Medical Center, Hamamatsu

Seirei Hamamatsu General Hospital, Hamamatsu

Juntendo University Shizuoka Hospital, Izunokuni

Tokushima Red Cross Hospital, Komatsushimachō

Ayase Heart Hospital, Adachi-ku

Juntendo University Hospital, Bunkyo-ku

The University of Tokyo Hospital, Bunkyo-ku

St. Luke's International Hospital, Chuo-ku

Sakakibara Heart Institute, Fuchū

Tokyo Metroporitan Tama Medical Center, Fuchū

Itabashi Chuo Medical Center, Itabashi-ku

Nihon University School of Medicine, Itabashi-ku

Teikyo University Hospital, Itabashi-ku

Tokyo Metroporitan Geriatric Hospital and Institute of Gerontology, Itabashi-ku

Toho University Medical Center Ohashi Hospital, Meguro-ku

The Cardiovascular Institute, Minato-ku

The Jikei University Hospital, Minato-ku

JR Tokyo General Hospital, Shibuya-ku

NTT Medical Center Tokyo, Shinagawa-ku

Tottri University, Yonago

Shuto General Hospital, Yanai

105-0013

Non-profit organization Associations for Establishiment of Evidence in Interventions, Minato-ku, Tokyo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Associations for Establishment of Evidence in Interventions

OTHER

NCT01325935 - Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients | Biotech Hunter | Biotech Hunter